Project Grant R21AI193834
Award Date 5/8/26
Completion Date 4/30/28
Dollars Obligated $273K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30329, USA
Similar Awards
- Federal Grant Award Summary Emory University received a $922,840 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 2, 2026 through January 31, 2031. The award supports research on Inducible Hepatic-Associated Lymphoid Tissue (iHALT) and the generation and maintenance of long-lived plasma cells during hepatotropic viral infection. The research utilizes a rodent...
- Federal Grant Award Summary Emory University received a $778,829 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 2, 2025, through May 31, 2030. The award funds a comprehensive research initiative to characterize early-life B-cell and antibody-secreting cell (ASC) development in the human spleen, with particular focus on understanding how naturally occurring plasma...
- Federal Project Grant Award Summary Emory University received a $412,749 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 6, 2026, with a completion date of January 31, 2028. The research project aims to identify and characterize cis-regulatory elements (enhancers) that facilitate precise genetic manipulation of specific B-cell subsets, including memory B cells (MBC) and...
- Federal Grant Award Summary Emory University received a $954,603 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded April 9, 2026, with completion targeted for March 31, 2028. The grant supports development of a novel long-acting injectable nanoparticle formulation encapsulating ALG-001075, a proprietary capsid assembly modulator (CAM) with pan-genotypic antiviral activity...
- Federal Grant Award Summary Emory University received a $909,998 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 5, 2026 through January 31, 2031. The grant supports research characterizing an antiretroviral therapy (ART)-free approach to establishing simian immunodeficiency virus (SIV) reservoirs using broadly neutralizing antibodies (BNAbs) and antibody-like...
- Federal Project Grant Award Summary Emory University's Office of Sponsored Programs received a $430,375 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, with completion scheduled for July 31, 2027. The award funds investigator-initiated biomedical research examining inter-membrane lipid signaling mechanisms in gram-negative bacteria, specifically focusing on...
- Federal Grant Award Summary Emory University received a $910K Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded May 5, 2026, with completion targeted for April 30, 2031. The grant supports investigator-initiated biomedical research focused on developing an innovative HIV vaccination strategy utilizing DNA-lipid nanoparticle (DNA-LNP) technology to induce durable cellular and...
- Federal Grant Award Summary Emory University received a $711,555 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective May 13, 2025, through April 30, 2030. The project delivers an integrated research and development framework combining graph neural networks with traditional compartmental models to advance understanding of spatiotemporal transmission dynamics and control...
- Federal Grant Award Summary Emory University received a $160,546 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on September 3, 2025, with a completion date of August 31, 2029. The award supports the development of a novel spatiotemporal machine learning framework designed to establish foundational epidemic models for respiratory infections. This research initiative leverages...
- Federal Grant Award Summary Emory University received a $2,297,892 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 17, 2025, with completion targeted for June 30, 2029. The award funds a four-year research investigation into the mechanisms by which interferon-induced transmembrane proteins (IFITMs) inhibit viral membrane fusion and restrict diverse enveloped viruses...